BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17912030)

  • 21. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree.
    Lesch KP; Selch S; Renner TJ; Jacob C; Nguyen TT; Hahn T; Romanos M; Walitza S; Shoichet S; Dempfle A; Heine M; Boreatti-Hümmer A; Romanos J; Gross-Lesch S; Zerlaut H; Wultsch T; Heinzel S; Fassnacht M; Fallgatter A; Allolio B; Schäfer H; Warnke A; Reif A; Ropers HH; Ullmann R
    Mol Psychiatry; 2011 May; 16(5):491-503. PubMed ID: 20308990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications.
    Gorringe KL; Jacobs S; Thompson ER; Sridhar A; Qiu W; Choong DY; Campbell IG
    Clin Cancer Res; 2007 Aug; 13(16):4731-9. PubMed ID: 17699850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated analysis of copy number alterations and loss of heterozygosity in human pancreatic cancer using a high-resolution, single nucleotide polymorphism array.
    Lin LJ; Asaoka Y; Tada M; Sanada M; Nannya Y; Tanaka Y; Tateishi K; Ohta M; Seto M; Sasahira N; Tada M; Kawabe T; Zheng CQ; Kanai F; Ogawa S; Omata M
    Oncology; 2008; 75(1-2):102-12. PubMed ID: 18787345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detailed genomic mapping and expression analyses of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification.
    Heidenblad M; Jonson T; Mahlamäki EH; Gorunova L; Karhu R; Johansson B; Höglund M
    Genes Chromosomes Cancer; 2002 Jun; 34(2):211-23. PubMed ID: 11979555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma.
    Fu B; Luo M; Lakkur S; Lucito R; Iacobuzio-Donahue CA
    Cancer Biol Ther; 2008 Oct; 7(10):1593-601. PubMed ID: 18769116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Large-scale copy number polymorphism in the human genome.
    Sebat J; Lakshmi B; Troge J; Alexander J; Young J; Lundin P; Månér S; Massa H; Walker M; Chi M; Navin N; Lucito R; Healy J; Hicks J; Ye K; Reiner A; Gilliam TC; Trask B; Patterson N; Zetterberg A; Wigler M
    Science; 2004 Jul; 305(5683):525-8. PubMed ID: 15273396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative genomic hybridization by representational oligonucleotide microarray analysis.
    Lucito R; Byrnes J
    Methods Mol Biol; 2009; 556():33-46. PubMed ID: 19488870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas.
    Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M
    J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide scan identifies a copy number variable region at 3q26 that regulates PPM1L in APC mutation-negative familial colorectal cancer patients.
    Thean LF; Loi C; Ho KS; Koh PK; Eu KW; Cheah PY
    Genes Chromosomes Cancer; 2010 Feb; 49(2):99-106. PubMed ID: 19847890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of ROMA (representational oligonucleotide microarray analysis) to patients with cytogenetic rearrangements.
    Jobanputra V; Sebat J; Troge J; Chung W; Anyane-Yeboa K; Wigler M; Warburton D
    Genet Med; 2005 Feb; 7(2):111-8. PubMed ID: 15714078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular and clinical analyses of 16q24.1 duplications involving FOXF1 identify an evolutionarily unstable large minisatellite.
    Dharmadhikari AV; Gambin T; Szafranski P; Cao W; Probst FJ; Jin W; Fang P; Gogolewski K; Gambin A; George-Abraham JK; Golla S; Boidein F; Duban-Bedu B; Delobel B; Andrieux J; Becker K; Holinski-Feder E; Cheung SW; Stankiewicz P
    BMC Med Genet; 2014 Dec; 15():128. PubMed ID: 25472632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer.
    Mahlamäki EH; Kauraniemi P; Monni O; Wolf M; Hautaniemi S; Kallioniemi A
    Neoplasia; 2004; 6(5):432-9. PubMed ID: 15548351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Linkage analysis of chromosome 4 in families with familial pancreatic cancer.
    Klein AP; de Andrade M; Hruban RH; Bondy M; Schwartz AG; Gallinger S; Lynch HT; Syngal S; Rabe KG; Goggins MG; Petersen GM
    Cancer Biol Ther; 2007 Mar; 6(3):320-3. PubMed ID: 17312386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of haploidy and triploidy based on measurement of gene copy number by real-time PCR.
    Wilke K; Duman B; Horst J
    Hum Mutat; 2000 Nov; 16(5):431-6. PubMed ID: 11058901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?
    Fanale D; Iovanna JL; Calvo EL; Berthezene P; Belleau P; Dagorn JC; Bronte G; Cicero G; Bazan V; Rolfo C; Santini D; Russo A
    Expert Opin Ther Targets; 2014 Aug; 18(8):841-50. PubMed ID: 24834797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNASEL germline variants are associated with pancreatic cancer.
    Bartsch DK; Fendrich V; Slater EP; Sina-Frey M; Rieder H; Greenhalf W; Chaloupka B; Hahn SA; Neoptolemos JP; Kress R
    Int J Cancer; 2005 Dec; 117(5):718-22. PubMed ID: 15981205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.
    Tersmette AC; Petersen GM; Offerhaus GJ; Falatko FC; Brune KA; Goggins M; Rozenblum E; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Clin Cancer Res; 2001 Mar; 7(3):738-44. PubMed ID: 11297271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candidate driver genes in focal chromosomal aberrations of stage II colon cancer.
    Brosens RP; Haan JC; Carvalho B; Rustenburg F; Grabsch H; Quirke P; Engel AF; Cuesta MA; Maughan N; Flens M; Meijer GA; Ylstra B
    J Pathol; 2010 Aug; 221(4):411-24. PubMed ID: 20593488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of genomic alterations in pancreatic cancer using array-based comparative genomic hybridization.
    Liang JW; Shi ZZ; Shen TY; Che X; Wang Z; Shi SS; Xu X; Cai Y; Zhao P; Wang CF; Zhou ZX; Wang MR
    PLoS One; 2014; 9(12):e114616. PubMed ID: 25502777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline variants in pancreatic cancer patients with a personal or family history of cancer fulfilling the revised Bethesda guidelines.
    Ohmoto A; Morizane C; Kubo E; Takai E; Hosoi H; Sakamoto Y; Kondo S; Ueno H; Shimada K; Yachida S; Okusaka T
    J Gastroenterol; 2018 Oct; 53(10):1159-1167. PubMed ID: 29667044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.